China SFDA Official Expects H1N1 Vaccine Shots To Ready In July
This article was originally published in PharmAsia News
Chinese authorities expect to have a vaccine against the A/H1N1 flu virus ready for inoculations by the end of July. They are counting on receipt of the strain in early June from the World Health Organization directly to drug makers, who are required to produce one following strict WHO protocols. The WHO had said slower-than-usual growth of the virus in laboratories meant the strain would not be available earlier than mid-July. The head of the State FDA's biology-production department said 11 drug companies are capable of producing seasonal flu vaccines, but only one can make the pandemic vaccine. (Click here for more
You may also be interested in...
A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.
Hikma has pushed back against a further attempt by Amarin to counter its US generic version of Vascepa, this time via a fresh lawsuit claiming that the generic induces infringement of patents protecting cardiovascular indications for which the brand is approved but which are carved out of the generic label.
The European Medicines Agency will continue working over the Christmas period so that it can complete its assessment of the newly filed marketing applications for BioNTech/Pfizer’s and Moderna’s COVID-19 vaccines as soon possible.